ARTICLE | Company News
Sonus restructures
October 20, 2000 7:00 AM UTC
SNUS began restructuring to refocus on the development of its drug delivery and blood substitute products following last week's withdrawal of an NDA for its EchoGen perflenapent ultrasound contrast ag...